Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 80.74%-381.2M | ---- | ---- | ---- | -67.14%-1.98B | ---- | ---- |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | ---- | ---- | 9.08%-51.18M | ---- | ---- | ---- | 30.01%-56.29M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 1,477.81%16.77M | ---- | ---- | ---- | ---1.22M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -90.15%64.72M | ---- | ---- | ---- | -18.97%656.89M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -90.25%52.82M | ---- | ---- | ---- | -32.47%541.47M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | 0.70%15.15M | ---- | ---- | ---- | 71.43%15.05M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -103.23%-3.25M | ---- | ---- | ---- | --100.37M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -57.77%6.15M | ---- | ---- | ---- | 258.23%14.56M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -57.77%6.15M | ---- | ---- | ---- | 258.23%14.56M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -76.75%75.78M | ---- | ---- | ---- | 171,473.68%325.99M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | --70.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -98.14%6.06M | ---- | ---- | ---- | 128,306.30%326.15M | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | -388.27%-791K | ---- | ---- | ---- | -153.13%-162K | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | -21.43%211.38M | ---- | ---- | ---- | 37.02%269.05M | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | -15.23%190.46M | ---- | ---- | ---- | 34.21%224.67M | ---- | ---- |
| -Other depreciation and amortization | ---- | ---- | ---- | -52.86%20.92M | ---- | ---- | ---- | 53.24%44.38M | ---- | ---- |
| Financial expense | ---- | ---- | ---- | 60.42%-22.36M | ---- | ---- | ---- | 69.28%-56.5M | ---- | ---- |
| Special items | ---- | ---- | ---- | -34.99%-13.14M | ---- | ---- | ---- | -76.27%-9.73M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 88.87%-93.08M | ---- | ---- | ---- | -88.91%-836.13M | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | 100.01%20K | ---- | ---- | ---- | 64.51%-214.35M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -126.98%-77.81M | ---- | ---- | ---- | 158.32%288.37M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | 38.02%-68.42M | ---- | ---- | ---- | 77.63%-110.39M | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 125.11%30.28M | ---- | ---- | ---- | -292.69%-120.58M | ---- | ---- |
| Cash from business operations | ---- | 98.31%-4.25M | ---- | 78.97%-208.87M | ---- | 68.24%-250.95M | ---- | 48.32%-993.08M | ---- | 36.37%-790.14M |
| Other taxs | ---- | ---130K | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest received - operating | ---- | -68.54%7.81M | ---- | -47.65%40.22M | ---- | -31.52%24.82M | ---- | 23.82%76.83M | ---- | 39.87%36.24M |
| Special items of business | ---- | ---- | ---- | ---137K | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment items of business operations | 111.65%33.49M | ---- | 87.24%-13.8M | ---- | 61.63%-287.41M | ---- | 68.68%-108.2M | ---- | 46.24%-748.97M | ---- |
| Net cash from operations | 111.65%33.49M | 101.51%3.42M | 87.24%-13.8M | 81.58%-168.79M | 61.63%-287.41M | 70.01%-226.13M | 68.68%-108.2M | 51.46%-916.25M | 46.24%-748.97M | 38.00%-753.91M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -57.80%28.55M | ---- | -83.55%7M | ---- | 32.18%67.66M | ---- | 141.14%42.57M | ---- | -40.46%51.19M | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---5.91M | ---- | ---5.91M | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | -103.52%-17.27M | ---- | 129.52%286.55M | ---- | 160.64%491.37M | ---- | -363.44%-970.67M | ---- | -284.99%-810.35M |
| Sale of fixed assets | 673.17%289.94K | ---- | ---- | -87.82%38K | -26.47%37.5K | ---- | ---- | --312K | --51K | --51K |
| Purchase of fixed assets | 45.21%-178.62M | 51.81%-102.18M | 49.88%-67.36M | 39.01%-357.16M | 27.11%-326.03M | 32.59%-212.02M | 37.55%-134.42M | 40.00%-585.57M | 48.15%-447.26M | 18.51%-314.51M |
| Purchase of intangible assets | ---- | 36.87%-32.21M | ---- | -303.59%-100.48M | ---- | -1,137.50%-51.02M | ---- | 74.86%-24.9M | ---- | 90.57%-4.12M |
| Sale of subsidiaries | ---- | ---- | ---- | ---1.31M | ---- | ---1.31M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---337K | ---380.77K | ---- |
| Recovery of cash from investments | -30.26%6.2B | -8.09%4.77B | 9.75%2.19B | 55.13%12.27B | 36.31%8.89B | 31.90%5.19B | -26.10%2B | -32.23%7.91B | -26.22%6.52B | -25.82%3.94B |
| Cash on investment | 32.87%-6.4B | 9.83%-4.92B | -19.67%-2.57B | -78.08%-12.18B | -80.96%-9.53B | -87.60%-5.46B | -0.44%-2.15B | 44.39%-6.84B | 49.47%-5.27B | 56.43%-2.91B |
| Other items in the investment business | -92.51%18.38M | -47.35%27.47M | -98.98%5.33M | 31.14%91.3M | 122.96%245.43M | 41.28%52.17M | 197.47%520.93M | -51.39%69.62M | -344.02%-1.07B | -42.06%36.93M |
| Net cash from investment operations | 49.48%-331.39M | -12,681.04%-278.04M | -259.03%-437.36M | 100.90%3.96M | -209.75%-655.97M | 103.25%2.21M | 259.88%275.01M | 62.95%-441.62M | 88.99%-211.77M | 94.79%-68M |
| Net cash before financing | 68.42%-297.9M | -22.64%-274.62M | -370.45%-451.16M | 87.86%-164.83M | 1.81%-943.38M | 72.76%-223.92M | 132.24%166.82M | 55.91%-1.36B | 71.03%-960.75M | 67.40%-821.9M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 7.96%765.66M | 18.28%634.75M | -8.64%288.22M | -38.09%1.04B | -46.30%709.2M | -48.24%536.63M | -23.01%315.48M | -36.04%1.69B | -40.15%1.32B | -37.22%1.04B |
| Refund | -52.08%-1.35B | -23.04%-752.36M | -114.08%-319.84M | 19.34%-1.3B | 37.22%-884.88M | 50.25%-611.47M | 61.90%-149.41M | -18.31%-1.62B | -15.53%-1.41B | -29.42%-1.23B |
| Issuing shares | ---- | --1.44M | ---- | -58.60%7.03M | ---- | ---- | ---- | --16.98M | ---- | --16.98M |
| Interest paid - financing | ---- | 24.43%-25.42M | ---- | 9.04%-63.78M | ---- | -22.02%-33.64M | ---- | -48.08%-70.12M | ---- | -58.51%-27.57M |
| Dividends paid - financing | 25.65%-36.63M | ---- | 22.41%-13.03M | ---- | 14.91%-49.27M | ---- | 27.18%-16.79M | 98.13%-3.63M | 74.29%-57.9M | ---3.63M |
| Other items of the financing business | 35.94%-5.1M | ---1.44M | 10.29%-1.71M | ---6.96M | -151.93%-7.96M | ---- | 62.12%-1.91M | ---- | 111.54%15.32M | ---- |
| Net cash from financing operations | -166.98%-621.81M | -29.32%-146.53M | -131.46%-46.37M | -4,307.60%-334.18M | -77.36%-232.9M | 48.99%-113.31M | 1,506.94%147.37M | -100.89%-7.58M | -120.89%-131.32M | -139.46%-222.14M |
| Effect of rate | -595.50%-6.14M | -153.89%-6.67M | -117.85%-2.61M | -57.04%8.72M | -101.70%-882.16K | -66.36%12.39M | 175.02%14.62M | -87.38%20.29M | -73.79%51.8M | -66.78%36.82M |
| Net Cash | 21.81%-919.71M | -24.88%-421.15M | -258.35%-497.53M | 63.45%-499.01M | -7.71%-1.18B | 67.70%-337.23M | 159.52%314.19M | 38.63%-1.37B | 59.38%-1.09B | 46.68%-1.04B |
| Begining period cash | -23.96%1.56B | -23.96%1.56B | -23.96%1.56B | -39.67%2.05B | -39.67%2.05B | -39.67%2.05B | -39.67%2.05B | -37.84%3.39B | -37.84%3.39B | -37.84%3.39B |
| Cash at the end | -27.50%629.96M | -34.47%1.13B | -55.55%1.06B | -23.96%1.56B | -63.04%868.93M | -27.80%1.72B | -16.49%2.37B | -39.67%2.05B | -20.70%2.35B | -33.93%2.38B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte Touche Tohmatsu, Deloitte Hua Yong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.